Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 22;126(13):3114–3121. doi: 10.1002/cncr.32907

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Memorial Sloan Kettering Cancer Center. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Clinical characteristics and peripheral blood methylation results of patients presenting with Wilms tumor (patients 1‐21) or hepatoblastoma (patients 22‐24) who underwent 11p15.5 methylation testing on the blood. Somatic mutations and tumor single‐nucleotide polymorphism (SNP) array results are shown for patients who underwent this testing. Somatic tumor mutations are shown for genes known to be associated with Wilms tumor or genes that were found to be mutated in multiple patients. GOM indicates gain of methylation; IC1, imprinting control 1; IC2, imprinting control 2; LOM; loss of methylation.